DEXILANT 30 MG CAP DURA LIB RETARD CT BL AL AL X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1063902610035 -
GGREM
501112070019302 -
Código de barras
7896641808982
O que a fonte publica
- Detentor do registro
- TAKEDA PHARMA LTDA.
- Princípios ativos
- DEXLANSOPRAZOL
- Embalagem
- 30 MG CAP DURA LIB RETARD CT BL AL AL X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- A2B2 - INIBIDORES DA BOMBA DE PRÓTONS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "DEXILANT 30 MG CAP DURA LIB RETARD CT BL AL AL X 30",
"holder": "TAKEDA PHARMA LTDA.",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896641808982"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "501112070019302",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "60.397.775/0001-74",
"priceRegime": "Regulado",
"productName": "DEXILANT",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "30 MG CAP DURA LIB RETARD CT BL AL AL X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "82.34",
"icms-12": "93.57",
"icms-17": "99.20",
"icms-18": "100.41",
"icms-19": "101.65",
"icms-20": "102.93",
"icms-21": "104.23",
"icms-22": "105.56",
"icms-23": "106.94",
"icms-17.5": "99.81",
"icms-19.5": "102.29",
"icms-20.5": "103.57",
"icms-22.5": "106.25",
"icms-12-alc": "83.54",
"icms-17-alc": "88.58",
"icms-18-alc": "89.66",
"icms-19-alc": "90.76",
"icms-20-alc": "91.90",
"icms-21-alc": "93.06",
"icms-22-alc": "94.25",
"icms-23-alc": "95.48",
"withoutTaxes": "73.52",
"icms-17.5-alc": "89.11",
"icms-19.5-alc": "91.33",
"icms-20.5-alc": "92.48",
"icms-22.5-alc": "94.86"
},
"pisCofinsList": "Negativa",
"substanceText": "DEXLANSOPRAZOL",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "110.46",
"icms-12": "125.52",
"icms-17": "133.07",
"icms-18": "134.70",
"icms-19": "136.36",
"icms-20": "138.08",
"icms-21": "139.82",
"icms-22": "141.60",
"icms-23": "143.46",
"icms-17.5": "133.89",
"icms-19.5": "137.22",
"icms-20.5": "138.94",
"icms-22.5": "142.53",
"icms-12-alc": "115.49",
"icms-17-alc": "122.46",
"icms-18-alc": "123.95",
"icms-19-alc": "125.47",
"icms-20-alc": "127.05",
"icms-21-alc": "128.65",
"icms-22-alc": "130.30",
"icms-23-alc": "132.00",
"withoutTaxes": "101.63",
"icms-17.5-alc": "123.19",
"icms-19.5-alc": "126.26",
"icms-20.5-alc": "127.85",
"icms-22.5-alc": "131.14"
},
"invalidBarcodes": [],
"activeSubstances": [
"DEXLANSOPRAZOL"
],
"therapeuticClass": "A2B2 - INIBIDORES DA BOMBA DE PRÓTONS",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1063902610035",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A2B2",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:501112070019302"